AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26656672
Drug: Smoking cessation
RxNorm normalized name: Zyban 150 MG Smoking Cessation 12 HR Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking cessation treatment (four 30-min behavioral counseling sessions)
Trial: 11834133
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg of tibolone, taken daily for 12 months
Trial: 11834133
Drug: Placebo pills,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo pills, taken daily for 12 months
Trial: 8510513
Drug: Intralipid 10%
RxNorm normalized name: Intralipid 10% Fat Emulsion for Injection
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralipid 10% (0.3 g triglyceride [TG]/kg/h for 6 hours)
Trial: 8510513
Drug: Lipidem (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipidem (0.1 g/kg/h for 6 hours)
Trial: 8510513
Drug: Both emulsions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both emulsions infused in random order (0.1 g/kg/h for 6 hours)
Trial: 26659550
Drug: Lurasidone 20
RxNorm normalized name: lurasidone 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone 20 mg/day
Trial: 23578605
Drug: ITCA 650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ITCA 650 (10, 20, 40, or 80 μg/d)
Trial: 23578605
Drug: ITCA 650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ITCA 650 (40 and 80 μg/d)
Trial: 21178082
Drug: DHA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA supplementation (400 mg/d from wk 20 of gestation through delivery)
Trial: 12488300
Drug: Gemcitabine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine alone (2,200 mg/m² biweekly)
Trial: 12488300
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus capecitabine (2,200 mg/m² gemcitabine biweekly + 2,500 mg/m² capecitabine days 1-7)
Trial: 9367703
Drug: Org 2766
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 2766 (2 mg)
Trial: 9367703
Drug: Org 2766
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org 2766 (4 mg)
Trial: 1552746
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (HDMTX, 1 g/m2)
Trial: 1552746
Drug: Successful remission
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Successful remission retrieval therapy
Trial: 27180101
Drug: Intramedullary implant
RxNorm normalized name: atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramedullary implant
Trial: 26391465
Drug: Monthly dosing
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly dosing of intravitreal 0.5 mg ranibizumab
Trial: 16627214
Drug: Antox (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antox (combined antioxidant preparation containing selenium, betacarotene, L-methionine, vitamins C and E)
Trial: 11014092
Drug: 99mTc injection
RxNorm normalized name: 99mTc medronate
DrugBank: Technetium Tc-99m medronate (DB09138)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 99mTc injection (20‐40 MBq)
Trial: 11014092
Drug: Blue dye
RxNorm normalized name: blue dye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blue dye injection
Trial: 11014092
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 99mTc and blue dye
Trial: 1464164
Drug: Rectal MST
RxNorm normalized name: MST 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal MST administration
Trial: 1464164
Drug: Oral MST
RxNorm normalized name: MST 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral MST administration
Trial: 1464164
Drug: Oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral and Rectal MST administration
Trial: 6389060
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g glucose with 50 g protein
Trial: 6389060
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g protein alone
Trial: 2197851
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g glucose alone
Trial: 6389060
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g glucose with 50 g protein (second meal)
Trial: 6389060
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g glucose (second meal)
Trial: 22144003
Drug: MENTHOL SPRAY
RxNorm normalized name: menthol Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MENTHOL SPRAY
Trial: 22144003
Drug: CONTROL SPRAY
RxNorm normalized name: Nix Lice Control Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CONTROL SPRAY
Trial: 22144003
Drug: CON (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CON (no spray)
Trial: 22144003
Drug: CON-SPRAY (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CON-SPRAY (control spray)
Trial: 20347088
Drug: 50-microg dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50-microg dose of misoprostol intravaginally 3 hours before oxytocin infusion
Trial: 29215519
Drug: Oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin infusion alone
Trial: 15218994
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 microg once daily for 42 days
Trial: 10926790
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day I‐3‐C
Trial: 10926790
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day I‐3‐C
Trial: 8395713
Drug: LMWH CY
RxNorm normalized name: Cys
DrugBank: Cysteine (DB00151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: LMWH CY 216 (n = 35), subcutaneous injection, 6 months
Trial: 8395713
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 40), no specific treatment
Trial: 216045
Drug: Amitriptyline treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline treatment
Trial: 28558452
Drug: Tailor-made notched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailor-made notched music therapy
Trial: 19873910
Drug: Electroacupuncture therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture therapy (Guanyuan (CV 4), Taixi (KI 3), Sanyinjiao (SP 6))
Trial: 19873910
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (antagonist scheme for ovulation induction without electroacupuncture)
Trial: 17032148
Drug: Risedronate (RIS)
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Risedronate (RIS) 30 mg daily by mouth for 60 days
Trial: 15863410
Drug: Cranberry juice
RxNorm normalized name: cranberry juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry juice (300 ml daily)
Trial: 12410197
Drug: Zinc-fortified ORS
RxNorm normalized name: zinc gluconate Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc-fortified ORS (40 mg/L)
Trial: 12410197
Drug: Zinc syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc syrup (15 mg for 6-11 months; 30 mg for 12-35 months)
Trial: 28747281
Drug: Transcutaneous electrical
RxNorm normalized name: Transcutaneous Electrical Nerve Stimulators (TENS Units) MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous electrical nerve stimulation (1-hour sessions twice daily for 10 weeks)
Trial: 28747281
Drug: Sham transcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham transcutaneous electrical nerve stimulation (1-hour sessions twice daily for 10 weeks)
Trial: 25526227
Drug: Once-daily, extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily, extended-release hydrocodone (Hysingla™ ER tablets)
Trial: 21653932
Drug: Acyclovir 400
RxNorm normalized name: acyclovir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 400 mg twice a day
Trial: 7619676
Drug: gamma-L-glutamyl-5-hydroxy-L-tryptophan (glu-5-HTP)
RxNorm normalized name: L-glutamyl-L-tryptophan
DrugBank: Oglufanide (DB05779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gamma-L-glutamyl-5-hydroxy-L-tryptophan (glu-5-HTP)
Trial: 7826829
Drug: carbidopa (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: carbidopa (100 mg)
Trial: 31449675
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of intervention components
Trial: 28662034
Drug: MA (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MA (20 mg Sb+5/kg/day for 20 days)
Trial: 28662034
Drug: LAMB (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAMB (3 mg/kg/day for 7 days)
Trial: 28662034
Drug: LAMB plus
RxNorm normalized name: Lamb
DrugBank: Lamb (DB10537)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAMB plus MA (10 mg/kg single dose plus 20 mg Sb+5/kg/day for 10 days)
Trial: 28662034
Drug: AmphoB (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmphoB (1 mg/kg/day for 14 days)
Trial: 20514956
Drug: Midazolam and
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam and morphine (group M)
Trial: 20514956
Drug: Ondansetron and
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron and morphine (group O)
Trial: 20514956
Drug: Morphine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine alone (group C)
Trial: 18541571
Drug: Selenium supplements
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplements (200 mug as selenomethionine)
Trial: 12482332
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy including irinotecan, oxaliplatin, and 5-fluorouracil (5-FU) with leucovorin
Trial: 7728786
Drug: Oral milrinone
RxNorm normalized name: Milrinone
DrugBank: Milrinone (DB00235)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral milrinone 2.5 mg
Trial: 7728786
Drug: Oral milrinone
RxNorm normalized name: Milrinone
DrugBank: Milrinone (DB00235)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral milrinone 5 mg
Trial: 7728786
Drug: Oral milrinone
RxNorm normalized name: Milrinone
DrugBank: Milrinone (DB00235)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral milrinone 10 mg
Trial: 2340612
Drug: Caudal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal block with 0.5 ml.kg‐1 of bupivacaine 0.25% following induction of anaesthesia before surgery
Trial: 7182948
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of butropium bromide (BB) at doses of 10 and 15 mg
Trial: 7182948
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration of butropium bromide (BB) at doses of 0.25 and 0.5 mg
Trial: 7182948
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration of butropium bromide (BB) at doses of 0.25-2.0 mg/person
Trial: 30590716
Drug: ACEi/ARBs +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACEi/ARBs + β-blockers
Trial: 30590716
Drug: Matched controls
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched controls without antihypertensive treatment
Trial: 28189123
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate (CPA) 10 mg/20 mg
Trial: 28189123
Drug: Levonorgestrel (LNG)
RxNorm normalized name: Levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levonorgestrel (LNG) 120 μg/240 μg
Trial: 28189123
Drug: Norethisterone acetate
RxNorm normalized name: Norethisterone acetate
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norethisterone acetate (NETA) 5 mg/10 mg
Trial: 28189123
Drug: Nestorone® (NES)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nestorone® (NES) 2 mg/3 mg
Trial: 28189123
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone (T)
Trial: 28189123
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of progestins with transdermal testosterone
Trial: 11904596
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptive
Trial: 23378537
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy with educational materials (EMs)
Trial: 21088596
Drug: Protective OLV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective OLV with tidal volume 6 ml/kg, FIO2 of 0.5, PEEP of 5 cmH2O
Trial: 21088596
Drug: Conventional OLV
RxNorm normalized name: Olvimulogene nanivacirepvec
DrugBank: Olvimulogene nanivacirepvec (DB16268)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional OLV with tidal volume 10 ml/kg, FIO2 of 1.0, no PEEP
Trial: 19552728
Drug: Ibandronate 6
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 6 mg intravenous every 4 weeks for 24 months
Trial: 12900686
Drug: Carbohydrate (CHO)
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate (CHO) ingestion (6.4%, 64 g x L‐1)
Trial: 10870740
Drug: Older generation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Older generation antidepressants (e.g., amitriptyline, nortriptyline)
Trial: 10870740
Drug: Anticonvulsant (e.g.,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticonvulsant (e.g., gabapentin)
Trial: 16086149
Drug: Chronic opioid
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic opioid therapy
Trial: 1643195
Drug: Diazepam 5
RxNorm normalized name: diazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 5 mg/70 kg
Trial: 1643195
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg/70 kg
Trial: 1643195
Drug: Diazepam (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (5 or 10 mg/70 kg)
Trial: 6487547
Drug: Minutes' therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minutes' therapy with dithranol in Lassar's paste
Trial: 6487547
Drug: Short-contact therapy
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-contact therapy with dithranol in Lassar's paste
Trial: 18824931
Drug: Caffeine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (6 mg x kg(‐1))
Trial: 21730779
Drug: Amoxicillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanic acid combination treatment for 10 days after abscess drainage
Trial: 21730779
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment for 10 days after abscess drainage
Trial: 19074638
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral exposure (10 s)
Trial: 15589853
Drug: Recombinant LH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant LH in addition to increased dose of FSH (group B)
Trial: 15589853
Drug: Increased dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased dosage of FSH (group A)
Trial: 15589853
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (D) with no need to increase FSH dose
Trial: 11694700
Drug: Oral penicillin
RxNorm normalized name: penicillin G Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral penicillin V
Trial: 8502522
Drug: Intramuscular benzathine
RxNorm normalized name: Cephapirin Benzathine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular benzathine penicillin G
Trial: 8502522
Drug: Oral erythromycin
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral erythromycin estolate
Trial: 14665353
Drug: Tamsulosin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.4 mg daily) for 30 days before biopsy
Trial: 14665353
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no tamsulosin treatment)
Trial: 12823087
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b therapy (5 million units 3 times per week or 3 to 5 million units 3 times per week with ribavirin 1000-1200 mg/day)
Trial: 2079571
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b therapy
Trial: 8892128
Drug: Discharge planning
RxNorm normalized name: Plan B One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Discharge planning and 8-week home follow-up provided by advanced practice nurses, including home visits, telephone outreach, and daily telephone availability.
Trial: 2059530
Drug: Conventional toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional toothbrush (Oral B 32)
Trial: 26979312
Drug: T-DM1 3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T-DM1 3.6 mg/kg every three weeks or 2.4 mg/kg weekly + paclitaxel 80 mg/m2 weekly ± pertuzumab 840 mg loading dose followed by 420 mg q3w
Trial: 24660647
Drug: Red laser
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red laser therapy (4 J/cm2 in temporomandibular joints and 8 J/cm2 in muscles, three sessions)
Trial: 24660647
Drug: Infrared laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infrared laser therapy (4 J/cm2 in temporomandibular joints and 8 J/cm2 in muscles, three sessions)
Trial: 21593809
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (200 µg sodium selenite/day for 3 weeks)
Trial: 20504899
Drug: Mixed insulins
RxNorm normalized name: insulin aspart protamine, human / insulin aspart, human Injectable Suspension [NovoLog Mix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed insulins (insulin detemir mixed with aspart)
Trial: 20504899
Drug: Separate insulins
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Separate insulins (insulin detemir and aspart given separately)
Trial: 17631952
Drug: Omalizumab +
RxNorm normalized name: Omalizumab
DrugBank: Omalizumab (DB00043)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Omalizumab + Ragweed immunotherapy
Trial: 17631952
Drug: Ragweed immunotherapy
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ragweed immunotherapy alone
Trial: 9706918
Drug: Lorazepam 60
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lorazepam 60 microg/kg p.o. (Group L)
Trial: 9706918
Drug: Morphine 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.1 mg/kg plus scopolamine 6 microg/kg i.m. (Group M)
Trial: 2403593
Drug: Selection of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selection of a drug by the capillary cloning system
Trial: 2403593
Drug: Selection of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selection of a drug by the clinician
Trial: 23200303
Drug: Atomoxetine (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (80 mg/day; p.o.)
Trial: 11337976
Drug: CLA supplementation
RxNorm normalized name: CLA
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CLA supplementation (3.9 g/d)
Trial: 2205704
Drug: pindolol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pindolol (15 mg)
Trial: 2439787
Drug: atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol (100 mg)
Trial: 788694
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (1 mg, orally, every 6 hours for two weeks)